Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Transdermal preparation

a technology of transdermal preparation and adhesive, which is applied in the field of transdermal preparation, can solve the problems of reducing the content of basic drugs, difficulty in containing basic drugs with 10 mass % or more in these adhesives, and affecting the effect of skin permeation rate, and good time-course stability of drugs

Active Publication Date: 2013-07-02
HISAMITSU PHARM CO INC
View PDF22 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0036]Regarding the transdermal preparation of the present invention, its production process is simple, and the drug can be transdermally absorbed at a stable skin permeation rate continuously for a long period of time, and time-course stability of the drug is good, and its adhesion to the skin is good, with only a little irritation to the skin; accordingly, the transdermal preparation of the present invention is extremely effective to the treatment of a wide range of disorders.

Problems solved by technology

However, because many basic drugs are low soluble to rubber adhesives and silicone adhesives, it is very difficult to contain a basic drug with 10 mass % or more in these adhesives while maintaining properties of the adhesives.
Meanwhile, to produce a transdermal administration preparation comprising a basic drug with the high concentration of 10 mass % or more, use of an acrylic adhesive having high polarity is advantageous in terms of solubility to drugs; however, many basic drugs react with acrylic acid alky ester or acrylic acid, i.e., a constitutional monomer of acrylic adhesives, possibly leading to a problem of a decrease in the drug content, etc.
However, when bisoprolol is orally administered, it may possibly induce symptoms such as bradycardia, dizziness, and malaise; from the viewpoint of stability of blood concentration over long period of time and sustainability of effects, development of transdermal administration preparations such as adhesive patches has been desired, rather than oral administration.
When SSRI such as fluvoxamine is orally administered to a patient, side effects such as nausea, diarrhea, and gastrointestinal tract disturbance are concerned, and defect of decreased compliance occurs such as withdrawal of taking the drug.
However, since an acrylic adhesive is used for the drug reservoir layer, the drug content tends to decrease during long period of storage.
However, in this literature, it is not that a basic drug is contained in a high concentration by means of comprising water-soluble polymer in the adhesive patch, and a means for achieving this is not provided as well.
However, this literature neither enables to contain a basic drug in a high concentration, nor provides a means for achieving this.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

examples

[0080]In the following, the present invention is explained in more details by way of examples. The present invention, however, is not limited to these examples. Furthermore, “%” means “mass %” unless otherwise expressly stated.

Evaluation of Drug Reservoir Layer

[0081]

TABLE 1Ex. 1Ex. 2Ex. 3Ex. 4Ex. 5Ex. 6Ex. 7Polyvinyl60%55%50%————pyrrolidone(low molecularweight)Polyvinyl———60%55%50%—pyrrolidone(high molecularweight)Hydroxypropyl————60%celluloseEudragit (R) EPO———————Acrylic adhesive———————(—COOHgroup-containingtype)Bisoprolol40%45%50%40%45%50%40%Comp.Comp.Comp.Ex. 8Ex. 9Ex. 10Ex. 11Ex. 12Ex. 1Ex. 2Ex. 3Polyvinyl————————pyrrolidone(low molecularweight)Polyvinyl————————pyrrolidone(high molecularweight)Hydroxypropyl55%50%——————celluloseEudragit (R) EPO——60%55%50%———Acrylic adhesive—————60%55%50%(—COOHgroup-containingtype)Bisoprolol45%50%40%45%50%40%45%50%Comp.Comp.Ex. 13Ex. 14Ex. 4Ex. 5Hydroxypropyl80%85%——celluloseAcrylic adhesive——80%85%(—OHgroup-containingtype)Fluvoxamine20%15%20%15%...

examples 1-14

[0082]In accordance with the mix ratio listed in the above table of formulation, ethanol was added and dissolved into each polymer, and bisoprolol or fluvoxamine was added and stirred sufficiently to give a coating solution. Then, the obtained coating solution was coated on a polyethylene terephthalate release film, the ethanol as the solvent was removed by drying, to form an adhesive layer. After obtaining a predetermined thickness (200 μm), the adhesive layer was laminated with a polyethylene terephthalate backing, giving a transdermal preparation (Examples 1-14) of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided is a transdermal preparation, which is capable of long-term (1-day to 7-day) release of a basic drug from a preparation, continuously and at a consistent concentration; shows little reduction over time in the drug content, even if multiple drugs are contained in the preparation; and is produced by a simple process. The transdermal preparation comprises a substrate, and an adhesive layer containing a basic drug and a water-soluble polymer.

Description

[0001]This patent application is a U.S. National Stage Application of International Application No. PCT / JP2010 / 057659, filed Apr. 30, 2010, which claims the benefit of priority from Japanese Application No. 2009-112234, filed May 1, 2009, teachings of each of which are herein incorporated by reference in their entirety.TECHNICAL FIELD[0002]The present invention relates to a transdermal preparation that continuously delivers a certain amount of a drug through the skin.BACKGROUND ART[0003]To obtain drug effects from a drug by its administration, an oral administration method is generally used; however, transdermal administration methods have many advantages over oral administration methods. For example, in an oral administration method, the drug absorbed in the bowel is, before it exhibits a drug effect in a desired site, first metabolized in the liver and most of its quantity is decomposed; whereas in a transdermal administration method, since the absorbed drug does not first pass th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): A61K9/70
Inventor AMANO, SATOSHISHINODA, TOMOHIROKASE, NATSUMI
Owner HISAMITSU PHARM CO INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products